Ying Wang

机构：Sun Yat-sen University, Capital Medical University, Sun Yat-sen Memorial Hospital, Beijing Chest Hospital, Shanghai Cell Therapy Research Institute · ORCID：0000-0003-0892-7858

发表论文 7 篇 · 总被引 18 次 · h-index 2

代表论文

• Liquid biopsy using plasma proteomics in predicting efficacy and tolerance of PD-1/PD-L1 blockades in NSCLC: a prospective exploratory study (2025 · Molecular Biomedicine · 被引 14)
• The safety, tolerability, and efficacy of BRY812 in patients with advanced solid tumors: Preliminary results from the phase I clinical study. (2025 · Journal of Clinical Oncology · 被引 2)
• Population Pharmacokinetics of Busulfan in Pediatric Patients: Optimization of a Four‐Times‐Daily Dosing Regimen Based on EBMT Recommendations (2025 · Pediatric Blood & Cancer · 被引 1)
• Association of LIV-1 expression with clinical efficacy in patients with advanced breast cancers treated with BRY812. (2025 · Journal of Clinical Oncology · 被引 1)
• Droplet Digital PCR Outperforms Conventional Methods for Early Relapse Prediction in Acute Myeloid Leukemia/Myelodysplastic Syndrome Patients Post-Transplantation (2025 · Transplantation and Cellular Therapy)
• Population pharmacokinetics of busulfan in pediatric patients: Optimization of a four-times-daily dosing regimen based on EBMT recommendations (2025)